WESTFIELD CAPITAL MANAGEMENT CO LP

Position in GILD — Gilead Sciences, Inc.

CIK 1177719 BOSTON, MA

Position in GILD

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$162,679,047

+$158,959,262 QoQ

Shares Held

1,287,629

+4724.4% QoQ

Ownership

0.104%

of shares outstanding

% of Portfolio

0.53%

of 13F equity value

Holder Rank

#98

of 2,266 holders

Holding Since

Jun 2022

10 quarters on record

Voting authority Sole 76% Shared 0% None 24%

Healthcare · as of Jun 30, 2026

WESTFIELD CAPITAL MANAGEMENT CO LP holds $691,252,397 across 8 Drug Manufacturers - General names. GILD ranks #2 (23.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	416,732	$499,840,904
2	GILD	Gilead Sciences, Inc. This page	1,287,629	$162,679,047
3	JNJ	Johnson & Johnson	35,772	$9,085,014
4	MRK	Merck & Co., Inc.	53,297	$6,848,664
5	AMGN	Amgen Inc	17,047	$6,173,059
6	PFE	Pfizer Inc	162,023	$3,901,513
7	ABBV	AbbVie Inc.	7,854	$1,976,380
8	NVO	Novo Nordisk A S	15,599	$747,816

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$162,679,047	1,287,629	+4724.4%	Shares	Sole	2026-08-12
2026-03-31	$3,719,785	26,690	-35.7%	Shares	Sole	2026-05-11
2025-12-31	$5,095,551	41,515	-58.9%	Shares	Sole	2026-02-11
2023-12-31	$8,180,470	100,981	+2.1%	Shares	Sole	2024-02-09
2023-09-30	$7,410,666	98,888	+6.6%	Shares	Sole	2023-11-13
2023-06-30	$7,148,319	92,751	+6.9%	Shares	Sole	2023-08-11
2023-03-31	$7,198,477	86,760	+3.8%	Shares	Sole	2023-05-12
2022-12-31	$7,176,630	83,595	+5.9%	Shares	Sole	2023-02-13
2022-09-30	$4,869,130	78,929	-2.9%	Shares	Sole	2022-11-14
2022-06-30	$5,022,371	81,255	—	Shares	Sole	2022-08-12
No filing history on record for this holder in this stock.